Upadacitinib,Adalimumab
Abbvie
['action,(-eaction),(-interaction)']
post-hoc analysis of select-compare showing decreased residual pain at week 12 but not week 26 cf. ada, regardless of residual inflammation. does this just reflect differing onset of action? abst0297 #acr22 
Rheumatology nerd. Opinions are my own (except when wrong)